Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence
Authors
Keywords
-
Journal
Pharmaceutics
Volume 15, Issue 11, Pages 2589
Publisher
MDPI AG
Online
2023-11-05
DOI
10.3390/pharmaceutics15112589
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluating Viscosity and Tear Breakup Time of Contemporary Commercial Ocular Lubricants on an In Vitro Eye Model
- (2023) Chau-Minh Phan et al. Translational Vision Science & Technology
- Analysis of tear film in cystinosis patients treated with topical viscous cysteamine hydrochloride (Cystadrop®)
- (2022) Petroni Sergio et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Diurnal variations of tear film osmolarity on the ocular surface
- (2022) Hugo Pena-Verdeal et al. Clinical and Experimental Optometry
- Hyaluronic Acid: Its Versatile Use in Ocular Drug Delivery with a Specific Focus on Hyaluronic Acid-Based Polyelectrolyte Complexes
- (2022) Saoirse Casey-Power et al. Pharmaceutics
- Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence
- (2022) Ana Castro-Balado et al. Pharmaceutics
- Hyaluronan and its derivatives for ophthalmology: Recent advances and future perspectives
- (2021) Gloria Huerta Angeles et al. CARBOHYDRATE POLYMERS
- A sustained release cysteamine microsphere/thermoresponsive gel eyedrop for corneal cystinosis improves drug stability
- (2021) Jorge Jimenez et al. Drug Delivery and Translational Research
- Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations
- (2021) Cristina Martín-Sabroso et al. Pharmaceuticals
- Challenges for cysteamine stabilization, quantification, and biological effects improvement
- (2020) Carla Atallah et al. Journal of Pharmaceutical Analysis
- Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride
- (2020) Hong Liang et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Hyaluronic Acid: The Influence of Molecular Weight on Structural, Physical, Physico-Chemical, and Degradable Properties of Biopolymer
- (2020) Petr Snetkov et al. Polymers
- Comparison study of two different topical lubricants on tear meniscus and tear osmolarity in dry eye
- (2019) Emine Esra Karaca et al. Contact Lens & Anterior Eye
- Nephropathic Cystinosis: Symptoms, Treatment, and Perspectives of a Systemic Disease
- (2018) Sören Bäumner et al. Frontiers in Pediatrics
- Novel approaches for improving stability of cysteamine formulations
- (2018) Phillip Dixon et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Comparison of 0.1%, 0.18%, and 0.3% Hyaluronic Acid Eye Drops in the Treatment of Experimental Dry Eye
- (2018) In Cheon You et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Evaluation of tear meniscus by optical coherence tomography after different sodium hyaluronate eyedrops instillation
- (2018) Gonzalo Carracedo et al. ACTA OPHTHALMOLOGICA
- A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye
- (2017) Yuli Park et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Diurnal variations in tear film break-up time determined in healthy subjects by software-assisted interpretation of tear film video recordings
- (2016) Hugo Pena-Verdeal et al. Clinical and Experimental Optometry
- Evaluation of Tear Meniscus Dynamics Using Anterior Segment Swept-Source Optical Coherence Tomography After Topical Solution Instillation for Dry Eye
- (2016) Reina Akiyama-Fukuda et al. CORNEA
- Effect of pH and penetration enhancers on cysteamine stability and trans-corneal transport
- (2016) Silvia Pescina et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Preformulation of cysteamine gels for treatment of the ophthalmic complications in cystinosis
- (2016) Barbara McKenzie et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Repeatability and Reproducibility of Noninvasive Keratograph 5M Measurements in Patients with Dry Eye Disease
- (2016) Lei Tian et al. Journal of Ophthalmology
- Osmolarity of Prevalent Eye Drops, Side Effects, and Therapeutic Approaches
- (2015) Ralf M. Dutescu et al. CORNEA
- Cystinosin is a Component of the Vacuolar H+-ATPase-Ragulator-Rag Complex Controlling Mammalian Target of Rapamycin Complex 1 Signaling
- (2015) Z. Andrzejewska et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Recent advances in ocular drug delivery
- (2012) Djamila Achouri et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Daytime Variations of Tear Osmolarity and Tear Meniscus Volume
- (2012) Ming Li et al. Eye & Contact Lens-Science and Clinical Practice
- Clinical evaluation of the Oculus Keratograph
- (2012) N. Best et al. Contact Lens & Anterior Eye
- Statistical guidelines for clinical studies of human vision
- (2011) Richard A Armstrong et al. OPHTHALMIC AND PHYSIOLOGICAL OPTICS
- Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis
- (2008) S BOZDAG et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started